ArticleBlood advances2025
RAS mutation identifies a poor prognostic molecular subtype of therapy-related myeloid neoplasm.
Chung Hoow Kok et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleBlood advances2025
Chung Hoow Kok et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.